Placebo for ORM-12741

DRUG2 trials

Sponsors

Orion Corporation, Orion Pharma

Conditions

Alzheimer's DiseaseHealthy

Phase 1

Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741

CompletedNCT01068028

Orion Corporation, Orion PharmaHealthy

Start: 2010-02-28End: 2010-07-31Updated: 2010-08-16

Phase 2

Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease

CompletedNCT01324518

Orion Corporation, Orion PharmaAlzheimer's Disease

Start: 2011-04-30End: 2012-10-31Updated: 2021-04-28